Zy Therapeutics

Zy TherapeuticsZy TherapeuticsZy Therapeutics

Zy Therapeutics

Zy TherapeuticsZy TherapeuticsZy Therapeutics
  • Home
  • About
  • The Problem
  • About BCDs
    • Sturge-Weber Syndrome
    • Tuberos Sclerosis
    • Neurocysticerosis
  • Our Solution
  • Who We Are
  • Corporate Communications
  • Contact Us
  • CTA
  • For Partners' Page
  • Publications
  • More
    • Home
    • About
    • The Problem
    • About BCDs
      • Sturge-Weber Syndrome
      • Tuberos Sclerosis
      • Neurocysticerosis
    • Our Solution
    • Who We Are
    • Corporate Communications
    • Contact Us
    • CTA
    • For Partners' Page
    • Publications
  • Home
  • About
  • The Problem
  • About BCDs
    • Sturge-Weber Syndrome
    • Tuberos Sclerosis
    • Neurocysticerosis
  • Our Solution
  • Who We Are
  • Corporate Communications
  • Contact Us
  • CTA
  • For Partners' Page
  • Publications

Who We Are

Jeffrey A. Loeb, MD, PhD Chief Medical and Scientific Officer

Jeffrey A. Loeb, MD, PhD

Tracy Jerome (“TJ”) Stalvey

Tracy Jerome (“TJ”) Stalvey

Chief Medical and Scientific Officer

Tracy Jerome (“TJ”) Stalvey Chief Operating Officer

Tracy Jerome (“TJ”) Stalvey

Tracy Jerome (“TJ”) Stalvey

Tracy Jerome (“TJ”) Stalvey

Chief Operating Officer

Dave Holecek

Tracy Jerome (“TJ”) Stalvey

Dave Holecek

Chief Commercial Officer

Keji Adewumi

Business Development and Strategy Associate

Connect With Us

Zy Therapeutics

Copyright © 2025 Zy Therapeutics - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept